AWM
DFTX

Activest Wealth Management’s Definium Therapeutics DFTX Stock Holding History

Activest Wealth Management’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.1K Hold
66
– – ﹤0.01% 788
2026
Q1 		$1.25K Hold
66
– – ﹤0.01% 1004
2025
Q4 		$884 Hold
66
– – ﹤0.01% 956
2025
Q3 		$778 Hold
66
– – ﹤0.01% 906
2025
Q2 		$428 Hold
66
– – ﹤0.01% 885
2025
Q1 		$386 Hold
66
– – ﹤0.01% 874
2024
Q4 		$459 Hold
66
– – ﹤0.01% 541
2024
Q3 		$376 Hold
66
– – ﹤0.01% 499
2024
Q2 		$476 Buy
+66
New +$577 ﹤0.01% 461
2021
Q4 		– Sell
-3
Closed -$1K – 372
2021
Q3 		$1K Buy
+3
New +$130 ﹤0.01% 353

Other funds holding DFTX

PFA
Peak Financial Advisors Denver, Colorado $242M AUM 19.63% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
BRG
Bay Rivers Group Williamsburg, Virginia $293M AUM 48.17% 1-Year Est. Return
SCI
Stableford Capital II Scottsdale, Arizona $289M AUM 20.84% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
CSP
Cary Street Partners Richmond, Virginia $4.58B AUM 24% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
WPW
Waldron Private Wealth Bridgeville, Pennsylvania $2.89B AUM 23.18% 1-Year Est. Return

Activest Wealth Management's DFTX Position: Q2 2026 in Review

Activest Wealth Management held its Definium Therapeutics (DFTX) position steady in Q2 2026 at 66 shares worth $3.1K. The position accounts for ﹤0.01% of the portfolio, ranked #788.

Activest Wealth Management first reported a position in DFTX in Q3 2021 and has held it in 10 quarters since. 20 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • Activest Wealth Management held 66 shares of Definium Therapeutics worth $3.1K as of Q2 2026.
  • Activest Wealth Management left its Definium Therapeutics share count unchanged in Q2 2026.
  • Definium Therapeutics made up ﹤0.01% of Activest Wealth Management's portfolio in Q2 2026, its #788 holding.
  • Activest Wealth Management first reported a position in Definium Therapeutics in Q3 2021 and has held it in 10 quarters since.
  • 20 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Activest Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.